1. Home
  2. SMWB vs CTMX Comparison

SMWB vs CTMX Comparison

Compare SMWB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

SELL

Current Price

$9.00

Market Cap

778.8M

Sector

Technology

ML Signal

SELL

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

SELL

Current Price

$2.53

Market Cap

716.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SMWB
CTMX
Founded
2007
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
778.8M
716.9M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SMWB
CTMX
Price
$9.00
$2.53
Analyst Decision
Buy
Strong Buy
Analyst Count
8
8
Target Price
$10.83
★ $12.25
AVG Volume (30 Days)
485.5K
★ 4.0M
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
★ $76,201,000.00
Revenue This Year
$11.98
N/A
Revenue Next Year
$11.01
$1.24
P/E Ratio
★ N/A
$22.58
Revenue Growth
★ N/A
N/A
52 Week Low
$2.22
$2.43
52 Week High
$9.50
$8.21

Technical Indicators

Market Signals
Indicator
SMWB
CTMX
Relative Strength Index (RSI) 64.07 34.17
Support Level $7.83 N/A
Resistance Level $9.50 $3.93
Average True Range (ATR) 0.42 0.14
MACD 0.11 0.00
Stochastic Oscillator 87.56 16.67

Price Performance

Historical Comparison
SMWB
CTMX

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: